As psychiatrists start to organize the next edition of the Diagnostic Statistical Manual of Mental Disorders, a debate has started on whether to include Internet addiction among our newest afflictions.
Drug companies sidestep rules and hide test results, according to researchers in Canada, France and Britain. David Moher of the Ottawa Hospital Research Institute said that there are two ways to let bias creep into a study: 1) decide the study doesn’t show what a drug company wanted to illustrate, and hide the whole thing, or 2) play up the good news in study findings while concealing the bad, known as “outcome reporting bias.”
Want to find a way to do something about the plight of our children at the hands of drug companies and misguided ‘mental health’ professionals? The International Center for the Study of Psychiatry and Psychology will hold a two-day conference on Friday and Saturday, October 9-10, 2009 in Syracuse, New York at the Renaissance Syracuse Hotel. It will feature international experts on on the adverse of effects of psychiatric drugs and better ways of helping children and families.
A Danish study shows that the risk is greatest when moms-to-be take more than one selective serotonin reuptake inhibitor (SSRI) antidepressant or switch SSRIs early in pregnancy. Babies born to women who had filled prescriptions for more than one SSRI had a fourfold increase in septal heart defects — a malformation of the wall that divides the left and right sides of the heart.
Eli Lilly & Co. agreed to settle, on confidential terms, lawsuits filed by seven states alleging the company improperly marketed its antipsychotic drug Zyprexa. The state lawsuits were seeking reimbursement for funds spent on Medicaid, the government health program for the poor. Zyprexa, part of a class of medications called atypical antipsychotics, has been linked to excessive weight gain and diabetes. The lawsuits also claim Lilly failed to properly warn of Zyprexa’s side effects.
SHARE YOUR STORY/COMMENT: